Vivos Therapeutics (VVOS) said Thursday is selling about 1.4 million common shares at $3.15 apiece in a registered direct offering for gross proceeds of roughly $4.3 million.
Priced at-the-market under Nasdaq rules, the offering is expected to close around Friday, the company said.
The company said it plans to use the net proceeds for working capital and general corporate purposes.
Shares of Vivos Therapeutics slid 23% in premarket activity on Thursday.
Price: 3.1800, Change: -0.95, Percent Change: -23.00
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments